Developing new therapies for Alzheimer's disease
IUSM TREAT-AD Center
This study is looking for new ways to treat Alzheimer's disease by exploring fresh ideas and developing new medications, so that patients can have better options for managing their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10950439 on NIH RePORTER |
What this research studies
The IUSM-Purdue TREAT-AD Center focuses on advancing the understanding and treatment of Alzheimer's disease by integrating innovative disease biology with drug discovery. This research aims to create Target Enabling Packages (TEPs) that explore new hypotheses related to Alzheimer's, moving beyond traditional amyloid beta approaches. By collaborating with a team of experts from multiple institutions, the project seeks to evaluate new therapeutic candidates using advanced cellular and animal models that reflect human disease. Patients may benefit from the development of novel treatments that target the underlying mechanisms of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking new therapies for Alzheimer's disease, improving outcomes for patients.
How similar studies have performed: Other research initiatives targeting novel pathways in Alzheimer's have shown promise, indicating potential for success in this approach.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Palkowitz, Alan D. — Indiana University Indianapolis
- Study coordinator: Palkowitz, Alan D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.